Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00164411 · ClinicalTrials.gov registry record · Phase 1
Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine
A Phase 1 study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00164411 is a Phase 1 study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 30 participants.
The verdict
NCT00164411, a Phase 1 study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to learn whether or not giving a tetanus/diphtheria vaccination ("tetanus shot") before giving pneumococcal vaccine makes the pneumococcal vaccine more effective without causing too many side effects.
Interventions
- BIOLOGICAL Tetanus-diphtheria toxoids (Td)
- BIOLOGICAL 7-valent pneumococcal conjugate vaccine
- BIOLOGICAL 23-valent polysaccharide vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2004-01 |
| Est. Completion | 2005-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00164411
The ClinicalTrials.gov registry entry for NCT00164411 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Tetanus-diphtheria toxoids (Td) is the first listed.
NCT00164411 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00164411 about?
NCT00164411 is a clinical study titled "Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine". The purpose of this study is to learn whether or not giving a tetanus/diphtheria vaccination ("tetanus shot") before giving pneumococcal vaccine makes the pneumococcal vaccine more effective without causing too many side effects.
What is the current status of trial NCT00164411?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2004-01. Estimated completion is 2005-03.
What interventions are being tested in trial NCT00164411?
The interventions under investigation include: Tetanus-diphtheria toxoids (Td) (BIOLOGICAL), 7-valent pneumococcal conjugate vaccine (BIOLOGICAL), 23-valent polysaccharide vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00164411?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.